Crowdonomics
All companies
CAVU Biotherapies, Inc. logo

CAVU Biotherapies, Inc.

Operating

Houston, TX

Visit website
Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$0
Across 1 round since 2017

Financials

FY2015–FY2016 · from SEC filings · hover any figure for its source
$0
−$36K
2015
$0
−$67K
2016
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2015
FY2016
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$35,570
-$66,978
Taxes paid
$0
$4,500
Balance sheet
Cash
$0
$6,419
Accounts receivable
$0
$0
Total assets
$0
$6,419
Short-term debt
$14,399
$61,213
Long-term debt
$0
$6,000
Total liabilities
$14,399
$67,213
Other
Headcount
—
1

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Reg CF Offering (2017)ClosedReg CF · SAFE · via WeFunder
Raised $0 / $1M

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form CMay 30, 20170001670254-17-000145
    EDGAR
Source: SEC EDGARCIK 0001696916DELast synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.